Evolutionary Medicine at Yale

Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for evolution of resistance to targeting of KRAS G12C. Oncogene.

Cannataro V.L., Gaffney S.G., Stender C., Zhao Z.-M., Philips M., Greenstein A., Townsend J.P.. 2018. Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for evolution of resistance to targeting of KRAS G12C. Oncogene..